NOTICE: Unless otherwise stated in our catalog or other product documentation, information presented in our scientific poster sessions is to be considered as Research Use Only.

 

Scientific Poster Presentations

2024

Endocrine Society

• Novel Comparative Analysis of Dried Blood Spot and Serum ELISAs for AMH, FSH, and LH in Patients Seeking IVF Treatment

Association for Diagnostics and Laboratory Medicine

• Development of Novel ELISAs for Total GDF-15 and H-Specific GDF-15
• Development of GIP ELISAs: The Next Level of Diabetes Management

2021

Endocrine Society

• PCOCheck AMH ELISA: A Clinical Case Report to Resolve Mismatched Antral Follicle Counts (AFC) to Serum AMH

2018

American Association of Clinical Chemistry

• Novel Biochemical Markers Help Aid in Stratifying Patients at Risk of Preeclampsia and Adverse Events

2017

American Association of Clinical Chemistry

• Development of Novel Specific and Sensitive ELISAs for Proglucagon-Derived Peptides

Endocrine Society

• Development of Novel ELISAs for Human GDF-9 and BMP-15 homodimers and the GDF-9:BMP-15 heterodimers

2016

Endocrine Society

• Validation of Dried Blood Spot AMH ELISA: A Convenient Alternative to Venipuncture
• Development of Well Characterized ELISAs for Bound and Unbound Insulin-Like Growth Factors and their Binding Proteins
• Development of Novel Specific ELISAs for all Inhibins, Activins and their Binding Proteins FST and FSTL3

2015

American Association of Clinical Chemistry

• Novel Anti-Müllerian Hormone ELISAs: Help Diagnose Polycystic Ovary Syndrome

2014

American Association of Clinical Chemistry

• Development of a sensitive Dried Blood Spot Anti-Müllerian Hormone (AMH) ELISA

European Society for Human Reproduction and Embryology

• Pre-analytical assessment of AMH stability in human serum using a well-characterized midpro-mature immunoassay

Endocrine Society Meeting

• Development of Stable picoAnti-Müllerian Hormone ELISA: Sensitive, Reliable and Reproducible Results
• Development of IGF-1 ELISA Assays to Measure Free and Total Circulating IGF-1

2013

Endocrine Society Meeting

• Development of a Well Characterized Ultra-Sensitive Human Anti-Mullerian Hormone Chemiluminescence Assay: Evaluation of Potential Clinical Applications

American Association for Clinical Chemistry

• Development and Validation of an Improved Chemiluminescent Assay for Inhibin B
• Development of a Sensitive Inhibin B ELISA Optimized to Eliminate False Positive Results
• New Sensitive Anti-Müllerian Hormone (AMH) ELISAs for Non-Human Primate, Rodent, Equine, Bovine, Canine and Other Species
• Development of a Well Characterized Ultra-Sensitive Human Anti-Müllerian Hormone (AMH) ELISA
• Development of a Broad-range, Sensitive, and Specific Immunoassay for Anti-Müllerian Hormone (AMH) with No Dilution Issues

American Society for Reproductive Medicine

• Analysis of Two Assays for the Measurement of AMH in Women with Low Ovarian Reserve
• Can AMH be Used as a Marker of Ovarian Reserve in Young Breast Cancer Patients Taking Tamoxifen?
• Can Ultra-Sensitive AMH Assays Detect Ovarian Function in Older Reproductive-Aged Women with Breast Cancer?

American Dairy Science Association

• Associations Between Plasma Anti-Müllerian Hormone and Fertility Responses of Seasonally Calving Grazing Dairy Cows

2012

Endocrine Society Meeting

• Development of a well characterized PAPP-A2 ELISA to measure PAPP-A2 in maternal biological fluids
• Development of a well characterized Total PAPP-A chemiluminescent assay for maternal serum evaluation

American Association for Clinical Chemistry

• Development of a fully characterized picoPAPP-A chemiluminescence assay for male and female serum evaluation
• Development of a well characterized PAPP-A2 chemiluminescence assay to measure PAPP-A2 in maternal biological fluids